Exclusive

Publication

Byline

Location

NATIONAL INSTITUTES OF HEALTH ISSUES NOTICE: CLINICAL CENTER; NOTICE OF CLOSED MEETING

WASHINGTON, April 21 -- National Institutes of Health has issued a notice called: Clinical Center; Notice of Closed Meeting. The notice was published in the Federal Register on April 21 by Bruce A. G... Read More


NATIONAL INSTITUTES OF HEALTH ISSUES NOTICE: CENTER FOR SCIENTIFIC REVIEW; AMENDED NOTICE OF MEETING

WASHINGTON, April 21 -- National Institutes of Health has issued a notice called: Center for Scientific Review; Amended Notice of Meeting. The notice was published in the Federal Register on April 21... Read More


HEALTH RESOURCES AND SERVICES ADMINISTRATION ISSUES NOTICE: NATIONAL VACCINE INJURY COMPENSATION PROGRAM LIST OF PETITIONS RECEIVED

WASHINGTON, April 21 -- Health Resources and Services Administration has issued a notice called: National Vaccine Injury Compensation Program List of Petitions Received. The notice was published in t... Read More


FOOD AND DRUG ADMINISTRATION ISSUES NOTICE: NOTICE OF APPROVAL OF PRODUCT UNDER VOUCHER: RARE PEDIATRIC DISEASE PRIORITY REVIEW VOUCHER; AMVUTTRA (VUTRISIRAN)

WASHINGTON, April 21 -- Food and Drug Administration has issued a notice called: Notice of Approval of Product Under Voucher: Rare Pediatric Disease Priority Review Voucher; AMVUTTRA (vutrisiran). Th... Read More


FOOD AND DRUG ADMINISTRATION ISSUES NOTICE: ACTION LEVELS FOR LEAD IN PROCESSED FOOD INTENDED FOR BABIES AND YOUNG CHILDREN; GUIDANCE FOR INDUSTRY; AVAILABILITY; CORRECTION

WASHINGTON, April 21 -- Food and Drug Administration has issued a notice called: Action Levels for Lead in Processed Food Intended for Babies and Young Children; Guidance for Industry; Availability; C... Read More


FOOD AND DRUG ADMINISTRATION ISSUES NOTICE: NOTICE OF APPROVAL OF PRODUCT UNDER VOUCHER: RARE PEDIATRIC DISEASE PRIORITY REVIEW VOUCHER; TREMFYA (GUSELKUMAB)

WASHINGTON, April 21 -- Food and Drug Administration has issued a notice called: Notice of Approval of Product Under Voucher: Rare Pediatric Disease Priority Review Voucher; TREMFYA (guselkumab). The... Read More


FOOD AND DRUG ADMINISTRATION ISSUES NOTICE: JOINT MEETING OF THE DRUG SAFETY AND RISK MANAGEMENT ADVISORY COMMITTEE AND THE ANESTHETIC AND ANALGESIC DRUG PRODUCTS ADVISORY COMMITTEE; AMENDMENT OF NOTICE-EXTENDED-RELEASE/LONG-ACTING OPIOID ANALGESIC POSTMARKETING REQUIREMENT

WASHINGTON, April 21 -- Food and Drug Administration has issued a notice called: Joint Meeting of the Drug Safety and Risk Management Advisory Committee and the Anesthetic and Analgesic Drug Products ... Read More


FOOD AND DRUG ADMINISTRATION ISSUES NOTICE: DETERMINATION THAT MOBIC (MELOXICAM) TABLETS, 7.5 MILLIGRAMS AND 15 MILLIGRAMS, WERE NOT WITHDRAWN FROM SALE FOR REASONS OF SAFETY OR EFFECTIVENESS

WASHINGTON, April 21 -- Food and Drug Administration has issued a notice called: Determination That MOBIC (Meloxicam) Tablets, 7.5 Milligrams and 15 Milligrams, Were Not Withdrawn From Sale for Reason... Read More


CENTERS FOR MEDICARE & MEDICAID SERVICES ISSUES NOTICE: MEDICARE PROGRAM; VIRTUAL MEETING OF THE MEDICARE EVIDENCE DEVELOPMENT AND COVERAGE ADVISORY COMMITTEE

WASHINGTON, April 21 -- Centers for Medicare & Medicaid Services has issued a notice called: Medicare Program; Virtual Meeting of the Medicare Evidence Development and Coverage Advisory Committee. Th... Read More


CENTERS FOR MEDICARE & MEDICAID SERVICES ISSUES NOTICE: MEDICARE PROGRAM: MEETING ANNOUNCEMENT FOR THE MEDICARE ADVISORY PANEL ON CLINICAL DIAGNOSTIC LABORATORY TESTS, JULY 23-24, 2025

WASHINGTON, April 21 -- Centers for Medicare & Medicaid Services has issued a notice called: Medicare Program: Meeting Announcement for the Medicare Advisory Panel on Clinical Diagnostic Laboratory Te... Read More